Alpha-2 Receptor Agonists Market

Alpha-2 Receptor Agonists Market Segmentation by Use (Hypertension, Attention-Deficit/Hyperactivity Disorder (ADHD), Pain & Panic Disorders, ICU & Procedural Sedation, and Others); and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Global Demand Analysis and Opportunity Outlook 2030

Buy Now
Report ID: 3265 | Published On: Apr 04, 2022

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022. Purchasing power in the country is expected to fell nearly by 2.5%.
On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.


In The News

  • April 2021: Merck Sharp & Dohme Corp. completed the acquisition of Pandion Therapeutics, making it a wholly-owned subsidiary of Merck.

  • April 2021: Pfizer Inc. announced that it had acquired Amplyx Pharmaceuticals, Inc. This acquisition has provided the company the opportunity for advancing its proficiency and deep heritage in treating infectious diseases.

  • October 2020: Mylan N.V. and Pfizer Inc. announced that they had received authorization from the U.S. Federal Trade Commission for proposed combination of Mylan and Upjohn Inc. This transaction sharpens their focus on innovative medicines and breakthroughs in the global healthcare market.  


Global Alpha-2 Receptor Agonists Market Highlights 2022-2030

The global alpha-2 receptor agonists market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2022-2030. The growing prevalence of hypertension and associated disorders, along with the increasing applications of alpha-2 receptor agonists are expected to fuel the progress of this market in the coming years. Along with this, the increasing elderly population and change in lifestyle patterns have given way to the prevalence of various metabolic disorders among people on a global scale, which is expected to lead to an increase in demand for drugs specialized in their treatment. Alpha-2 receptor agonists are increasingly being adopted for treatment as they can reduce blood pressure by inhibiting sympathetic activity in the brain, which in turn is anticipated to drive market growth in the future. The growth of the market can also be attributed to factors such as the rising consumption of unhealthy food, and growing alcohol and tobacco intake on a global level. Furthermore, rising number of incidences of hypertension in lower income nations is expected to provide growth opportunities to the market in the forecast period. According to the data collected from World Health Organization, it was estimated that in 2019, 1.13 billion people globally had hypertension, of which two-thirds of people were living in low and middle-income regions.

Global-Alpha-2-Receptor-Agonists-Market-Overview

Get more information on this reportDownload Sample PDF

The market is segmented on the basis of use into hypertension, attention-deficit/hyperactivity disorder (ADHD), pain & panic disorders, ICU & procedural sedation, and others, out of which, the hypertension segment is anticipated to grab the largest share by the end of 2030 on account of high prevalence of hypertension worldwide. Moreover, the increase in consumption of unhealthy food which is one of the major risk factors for hypertension, is also projected to contribute to the growth of the segment during the forecast period. Additionally, on the basis of distribution channel, the hospital pharmacies segment in the global alpha-2 receptor agonists market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that a considerable portion of the population around the world with hypertension and associated disorders tend to choose hospital facilities for treatment. 


Major Macro-Economic Indicators Impacting the Market Growth

Global-Healthcare-Expenditure-per-Capita

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Global Alpha-2 Receptor Agonists Market Regional Synopsis

Geographically, the global alpha-2 receptor agonists market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing incidence of hypertension-related disorders and growing penetration of alpha-2 receptor agonists in the region. Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to the rise in prevalence of attention deficit/hyperactivity disorder (ADHD), accompanied by the presence of leading market players in the region. Along with this, North America also leads in terms of advancements in clinical research, which is also expected to contribute to the region’s market growth in the near future. Alternatively, the market in Europe is also anticipated to occupy a significant share on account of the increasing prevalence of cardiovascular diseases and rising awareness about hypertension in the region. As per the data published in the journal Annals of Global Health in 2020, cardiovascular diseases (CVD) are the leading cause responsible for deaths in Europe and accounts for 45% of the total number of deaths in the region. More than 4 million individuals in Europe suffer death annually from cardiovascular diseases.

Global-Alpha-2%20Receptor-Agonists-Market-Share

Get more information on this reportDownload Sample PDF

The global alpha-2 receptor agonists market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis


Global-Alpha-2-Receptor-Agonists-Market-Overview
Get more information on this report: Request Sample PDF

Market Segmentation

Our in-depth analysis of the global alpha-2 receptor agonists market includes the following segments:

By Use

  • Hypertension
  • Attention-Deficit/Hyperactivity Disorder (ADHD)
  • Pain & Panic Disorders
  • ICU & Procedural Sedation
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Growth Drivers

  • Increasing Prevalence of Hypertension and Associated Disorders
  • Growing Applications of Alpha-2 Receptor Agonists

Challenges

  • Strict Regulations Regarding Medicine Approval
  • Adverse Effects of Alpha-2 Receptor Agonists such as Sedation & Fatigue


Global-Healthcare-Expenditure-per-Capita

Key Questions Answered in the Report

1) What are the major factors driving the growth of the alpha-2 receptor agonists market?

Ans: The increasing prevalence of hypertension and growing applications of alpha-2 receptor agonists are the key factors driving market growth.

2) What would be the CAGR of alpha-2 receptor agonists market over the forecast period?

Ans: The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2022-2030.

3) What are the challenges affecting the alpha-2 receptor agonists market growth?

Ans: Strict regulations with medicine approval and the adverse effects of alpha-2 receptor agonists such as sedation & fatigue are estimated to hamper market growth.

4) Which region will provide more business opportunities for growth of alpha-2 receptor agonists market in future?

Ans: The market in Asia Pacific region will provide ample growth opportunities to the market owing to the increasing incidence of hypertension-related disorders among the individuals.

5) Who are the major players dominating the alpha-2 receptor agonists market?

Ans: The major players dominating the alpha-2 receptor agonists market are Pfizer Inc., Merck Sharp & Dohme Corp., Mylan N.V., and Amneal Pharmaceuticals LLC, among others.

6) How are the company profiles selected?

Ans: The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the alpha-2 receptor agonists market?

Ans: The market is segmented by use, distribution channel, and by region.

8) Which segment under the distribution channel segment captures the largest market size in the alpha-2 receptor agonists market?

Ans: With respect to distribution channel, the hospital pharmacies segment is anticipated to hold the largest market share owing to the preference of the population with hypertension and associated disorders choose hospital facilities for treatment.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample